Stem cell research proves beneficial and controversial – KTAL
|
Stem cell research proves beneficial and controversial
KTAL It’s a debate that puts many people’s religious beliefs at odds with science. Medical breakthroughs have allowed doctors to use human stem cells to treat chronic diseases with incredible results, but even patients who benefit have reservations about … |
Channel News Asia |
Athersys tanks as its stem cell therapy flunks a Phase II stroke trial
FierceBiotech Athersys’ ($ATHX) in-development stem cell treatment failed to beat placebo in a Phase II trial on stroke patients, demolishing the company’s value as management digs for a positive spin. The company’s treatment, called MultiStem, is meant to reverse … Athersys’ stroke clinical trial yields disappointing resultsCrain’s Cleveland Business |
Channel News Asia |
Athersys tanks as its stem cell therapy flunks a Phase II stroke trial
FierceBiotech Athersys’ ($ATHX) in-development stem cell treatment failed to beat placebo in a Phase II trial on stroke patients, demolishing the company’s value as management digs for a positive spin. The company’s treatment, called MultiStem, is meant to reverse … Athersys’ stroke clinical trial yields disappointing resultsCrain’s Cleveland Business |
Channel News Asia |
Athersys tanks as its stem cell therapy flunks a Phase II stroke trial
FierceBiotech Athersys’ ($ATHX) in-development stem cell treatment failed to beat placebo in a Phase II trial on stroke patients, demolishing the company’s value as management digs for a positive spin. The company’s treatment, called MultiStem, is meant to reverse … Athersys’ stroke clinical trial yields disappointing resultsCrain’s Cleveland Business |